The present work, therefore, contributes to the understanding of FBXW11 role in osteogenic cells by evaluating its modulation both during osteogenic commitment and in altered osteoblastic cells characterized by RUNX2 mutations or resulting from tumour transformation. Here, FBXW11 is linked to neoplasm.